Home > Drug Search >
  • company_query: Breakthrough Therapeutics
  •   > 
Drug Filter
Category:
chemistry (5) biology (25)
Status:
Approved (1) Withdrawn (1) Phase Ⅲ (3) Phase Ⅱ (18) Phase Ⅰ (7)
Clinical Stage:
Pending (2) Active (18) Discontinued (8)
Bio-Type:
Gene therapy (2) Cell therapy (2) CAR T cell therapy (1) Vaccine (16) Animal extract (1) Recombinant cytokines (1)
Indication:
Non-alcoholic steatohepatitis (1) Acute lymphoblastic leukaemia (ALL) (1) Acute myeloid Leukemia (AML) (1) Amyotrophic lateral sclerosis (ALS) (1) Atopic dermatitis (1) Breast cancer (1) Chronic myeloid leukemia (CML ) (1) Chronic obstructive pulmonary disease (COPD) (1) Coronary artery disease (CAD) (1) Cystic fibrosis (CF) (1) Follicular lymphoma (1) HBV infection (1) HCV infection (1) Alcoholic hepatitis (1) Hepatocellular carcinoma (HCC) (1) HIV infection (4) Influenza virus infection (3) Major depressive disorder (MDD) (1) Melanoma (2) Multiple myeloma (MM) (2) Multiple sclerosis (MS) (1) Neuropathic pain (1) Non-Hodgkin B-cell lymphomas (1) Pancreatic cancer (1) Prostate cancer (2) Schizophrenia (1) Solid tumours (3) Rotavirus infection (1) Ulcerative colitis (1) Influenza A virus infections (1) Colorectal cancer (2) Helicobacter pylori infection (1) Anthrax (1) Pain (1) Autistic disorder (1) Anesthesia (1) Sarcoma (2) Malaria (1) Renal carcinoma (1) Glioma (1) Allergic asthma (1) Diffuse large B cell lymphoma (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top